Anemia Flashcards
O2 content calculation
CaO2= (Hgb x 1.39)SaO2 + PaO2 * 0.003
Chronic Anemia Anesthetic Goals:
Avoid disruption of compensatory mechanisms
Maximize O2 deliver; give O2 and PEEP
Avoid drug-induced decreases in CO
Volatile anesthetic effects will be accelerated (dec solubility of blood)
Avoid conditions that favor leftward shift (hyperventilation/alk; hypothermia)
Compensatory mechanisms for chronic anemia
increased: CO, 2,3-DPG; P-50; plasma volume;
decreased: blood viscosity, SVR
RIGHTward shift
Redistribution of blood to organs with higher extraction ratio
Anesthetic management in Folic Acid Deficiency
avoid regional and PNB (neuropathies)
Avoid N2O
Maintain PaO2
Assess airway- smooth tongue
Hemolytic anemia anesthetic management
Increased risk of tissue hypoxia
splenectomy increases infection risk
erythropoeitin prescribed 3 days prep
Acute drops below 8 and chronic below 6 considered for transfusion
preoperative hydration and caution METHYLENE BLUE
increased risk of venous thrombosis (increased coag)
Thalassemia considerations
Coagulopathy (question regional)
Hypersplenism (thrombocytopenia and increased risk of infection)
MAXILLARY DEFORMITIES
Complications of iron loading: Diabetes, adrenal insufficiency, liver dysfunction and coagulation abn; hypothyroid/parathyroidism; arrythmias; right sided heart failure
Spinal cord compression
HR- watch arrythmias
Aplastic anemia considerations
steroid stress dosing (pts on immunosup)
reverse isolation; prophylactic antibioitics
hemorrhage possible with DVL; consider transfusions before
difficulty crossmatching blood
regional anesthesia (caution bleeding epidural hematoma)
Avoid N2O
Use PEEP to facilitate decreased FIO2 (BMS)
Sickle Cell considerations
- HYPOXEMIA 2. HYPOVOLEMIA 3. STASIS
transfusion goal to decrease Hgb S to
Hemophilia A; what level is low? and what is treatment?
VIII Infusion of Factor VIII; 50-60 U/kg , repeated infusion 25-30 U/K every 8-12 hours. Continue for 2 weeks Keep plasma factor VIII level above 50% half life is 12 hours
Hemophilia B: what is low, and what is treatment?
Factor IX; dose 100 U/kg; repeat 12-24 hrs at 50 U/kg.
(Increased risk of thromboembolic complications, can activate other clotting cascades
Hemophilia A anesthetic management
risk of bleeding with regional (contraindicated)
careful DVL
avoid IM
Von Willebrand’s disease anesthetic considerations and treatment:
avoid nasal intubations/trumpets
DDAVP for mild bleeding/surgery: 0.3 mcg/kg (in 30-50mL) over 10-20 min.
Cryoprecipitate for severe bleeding or prophylaxis: contains fibrinogen, VWF, VIII, XIII
Factors that cause platelet dysfunction:
Hypothermia, acidosis, uremia
Treatment: cWF in cryoprecipitate, desmopressin, platelet transfusion
Treatment for methemoglobinemia:
influences the accuracy of pulse oximetery as methemoglobin absorbs light equally in both red and infrared.
O2 therapy
1-2 mg/kg of intravenous methylene blue as a 1% solution in saline infused over 3-5 minutes (may be repeated after 30 mins)
Factors interfering with O2 delivery to tissues
decreased CO
LEFTWARD shift of curve: respiratory alk; hypothermia; abnormal Hgb (fetal Hgb and carboxyhemoglobin)